Stock Comparison
ARGX vs JAZZ
argenx NV ADR and Jazz Pharmaceuticals PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$15.96B
P/E (TTM)
32.7
16.8
Forward P/E
30.4
10.3
Price/Sales
10.0
3.5
Price/Book
6.4
3.3
EV/EBITDA
27.6
11.3
Dividend Yield
—
—
Profitability
Net Margin
30.44%
0.66%
Operating Margin
27.34%
11.13%
Return on Equity
23.60%
22.10%
Return on Assets
11.60%
6.86%
Growth (YoY)
Revenue Growth
59.30%
15.50%
Earnings Growth
95.20%
3.20%
Price & Risk
Beta
-0.0
0.4
52-Week High
$939.68
$261.62
52-Week Low
$652.43
$116.67
Analyst Target
$1,085.78
$280.95
Compare ARGX and JAZZ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.